WINDTREE THERAPEUTICS INC /DE/ Increase (Decrease) in Inventories
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Increase (Decrease) in Inventories of $0 for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2017-03-31
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in inventories for the quarter ending 2016-03-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in inventories for the quarter ending 2015-12-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in inventories for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in inventories for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in inventories for fiscal 2015 was -$201.00K, a 111.24% decline from fiscal 2014.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in inventories for fiscal 2014 was $1.79M, a 314.85% increase from fiscal 2013.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in inventories for fiscal 2013 was $431.00K, a 121.03% increase from fiscal 2012.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in inventories for fiscal 2012 was $195.00K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2016-03-31 | $0.00 10-Q · filed 2016-05-12 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | $0.00 derived: sum of 3 quarters · filed 2017-03-31 | $0.00 derived: sum of 4 quarters · filed 2017-03-31 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | $0.00 derived: sum of 3 quarters · filed 2017-03-31 | -$201.00K 10-K · filed 2017-03-31 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | -$201.00K 10-Q · filed 2016-11-14 | -$732.00K derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$201.00K 10-Q · filed 2016-08-10 | -$732.00K derived: sum of 3 quarters · filed 2016-08-10 | -$609.00K derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2015-03-31 | -$201.00K 10-Q · filed 2016-05-12 | -$732.00K derived: sum of 2 quarters · filed 2016-05-12 | -$609.00K derived: sum of 3 quarters · filed 2016-05-12 | $504.00K derived: sum of 4 quarters · filed 2016-05-12 | |||
| 2014-12-31 | -$531.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$408.00K derived: sum of 2 quarters · filed 2016-03-29 | $705.00K derived: sum of 3 quarters · filed 2016-03-29 | $1.79M 10-K · filed 2016-03-29 | |||
| 2014-09-30 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $1.24M derived: sum of 2 quarters · filed 2015-11-05 | $2.32M 10-Q · filed 2015-11-05 | $2.83M derived: sum of 4 quarters · filed 2015-11-05 | |||
| 2014-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $2.20M 10-Q · filed 2015-08-10 | $2.71M derived: sum of 3 quarters · filed 2015-08-10 | $2.79M derived: sum of 4 quarters · filed 2015-08-10 | |||
| 2014-03-31 | $1.08M 10-Q · filed 2015-05-11 | $1.59M derived: sum of 2 quarters · filed 2015-05-11 | $1.67M derived: sum of 3 quarters · filed 2015-05-11 | $1.71M derived: sum of 4 quarters · filed 2015-05-11 | |||
| 2013-12-31 | $509.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $590.00K derived: sum of 2 quarters · filed 2015-03-16 | $626.00K derived: sum of 3 quarters · filed 2015-03-16 | $431.00K 10-K · filed 2015-03-16 | |||
| 2013-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $117.00K derived: sum of 2 quarters · filed 2014-11-07 | -$78.00K 10-Q · filed 2014-11-07 | -$11.00K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2013-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$159.00K 10-Q · filed 2014-08-07 | -$92.00K derived: sum of 3 quarters · filed 2015-03-16 | -$69.00K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2013-03-31 | -$195.00K 10-Q · filed 2014-05-12 | -$128.00K derived: sum of 2 quarters · filed 2015-03-16 | -$105.00K derived: sum of 3 quarters · filed 2015-03-16 | $0.00 derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2012-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $90.00K derived: sum of 2 quarters · filed 2015-03-16 | $195.00K derived: sum of 3 quarters · filed 2015-03-16 | $195.00K 10-K · filed 2015-03-16 | -$195.00K 10-K · filed 2013-03-15 | ||
| 2012-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $128.00K derived: sum of 2 quarters · filed 2013-11-12 | $128.00K 10-Q · filed 2013-11-12 | -$128.00K 10-Q · filed 2012-11-14 | $128.00K derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $105.00K 10-Q · filed 2013-08-08 | -$105.00K 10-Q · filed 2012-08-14 | $105.00K derived: sum of 3 quarters · filed 2014-03-17 | $105.00K derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-07 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 derived: sum of 3 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | |||||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-14 | ||||||
| 2010-12-31 | $0.00 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |